Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Ecancermedicalscience ; 16: 1396, 2022.
Article in English | MEDLINE | ID: mdl-35919242

ABSTRACT

Introduction: Recently, contrast-enhanced mammography (CEM) has emerged as a reliable alternative to breast magnetic resonance imaging (MRI) for the assessment of pathological response in breast cancer patients. Our study sought to determine the diagnostic accuracy of CEM to predict pathological complete response (pCR) in patients who received neoadjuvant chemotherapy (NACT). Methods: We retrieved the medical records of patients who underwent NACT at our institution. Using post-surgery pCR, morphological evidence and CEM enhancement tumours were classified as follows: 1) radiologic complete response (rCR); 2) functional radiological complete response (frCR); and 3) non-complete response. Initially, we used multivariate analyses adjusted by clinical variables and frCR or rCR to determine which variables affected pathological response. Then, CEM diagnostic accuracy to discriminate pCR was assessed using receiver operating characteristic curves in univariate and multivariate models including either frCR or rCR. Results: A total of 48 patients were included in our study. Most patients (68.7%) were hormone receptor (HR)+ and 41.6% (20) of the patients achieved pCR. Using univariate logistic regression analyses we found that HR status, HER2 status, rCR and frCR had a significant impact on CEM diagnostic accuracy. Exploratory analyses found that CEM sensitivity was higher for HR- tumours. Multivariate logistic regression analyses found 60% sensitivity, 92.9% specificity and 79.2% accuracy in a model that included clinical variables and rCR. Conclusion: CEM is a reliable alternative to high-cost, time-consuming breast MRI that predicts pCR in patients undergoing NACT; CEM diagnostic accuracy was higher among patients who harboured HR- tumours.

2.
Nanomedicine (Lond) ; 13(20): 2597-2609, 2018 10.
Article in English | MEDLINE | ID: mdl-30338706

ABSTRACT

Breast cancer is one of the most frequently diagnosed cancers and the leading cause of cancer-related deaths in women worldwide, whereby mortality is largely attributable to the development of distant metastasis. Caveolin-1 (CAV1) is a multifunctional membrane protein that is typically upregulated in the final stages of cancer and promotes migration and invasion of tumor cells. Elevated levels of CAV1 have been detected in extracellular vesicles (EVs) from advanced cancer patients. EVs are lipid enclosed vesicular structures that contain bioactive proteins, DNA and RNAs, which can be transferred to other cells and promote metastasis. Therefore, we hypothesized that CAV1 containing EVs released from breast cancer cells may enhance migration and invasion of recipient cells. EVs were purified from conditioned media of MDA-MB-231 wild-type (WT), MDA-MB-231 (shCAV1; possessing the plasmid pLKO.1 encoding a 'small hairpin' directed against CAV1) and MDA-MB-231 (shC) short hairpin control cells. Nanoparticle tracking analysis revealed an average particle size of 40-350 nm for all preparations. As anticipated, CAV1 was detected in MDA-MB-231 WT and shC EVs, but not in MDA-MB-231 (shCAV1) EVs. Mass spectrometry analysis revealed the presence of specific cell adhesion-related proteins, such as Cyr61, tenascin (TNC) and S100A9 only in WT and shC, but not in shCAV1 EVs. Importantly, EVs containing CAV1 promoted migration and invasion of cells lacking CAV1. We conclude that the presence of CAV1 in EVs from metastatic breast cancer cells is associated with enhanced migration and invasiveness of recipient cells in vitro, suggesting that intercellular communication promoted by EVs containing CAV1 will likely favor metastasis in vivo.


Subject(s)
Breast Neoplasms/drug therapy , Breast Neoplasms/genetics , Caveolin 1/genetics , Cell Adhesion/drug effects , Breast Neoplasms/chemistry , Breast Neoplasms/pathology , Caveolin 1/chemistry , Cell Communication/drug effects , Cell Movement/drug effects , Extracellular Vesicles/chemistry , Female , Humans , MCF-7 Cells , Neoplasm Metastasis
3.
Rev. colomb. cir ; 25(2): 104-120, abr.-jul. 2010. tab, ilus
Article in Spanish | LILACS | ID: lil-560908

ABSTRACT

Objetivo: proponer una guía de manejo para la nutrición en los pacientes con pancreatitis aguda grave basada en la mejor evidencia disponible. Diseño: revisión sistemática y guía de práctica clínica. Población: pacientes críticos con pancreatitis aguda grave hospitalizados en la unidad de cuidados intensivos. Intervenciones y controles: nutrición entérica Vs. parenteral; dieta hipocalórica Vs. normocalórica; glutamina Vs. sin glutamina; arginina Vs. sin arginina; ácidos grasos omega 3/omega 6 Vs. omega 6 solamente; prebióticos o probióticos Vs. dieta estándar. Desenlaces: mortalidad, estancia hospitalaria y en la unidad de cuidados intensivos y, infecciones y sepsis, disfunción de órganos. Materiales y métodos: búsqueda en bases de datos médicas en línea. Resultados: las 765 referencias iniciales fueron filtradas con las palabras clave y quedaron 69 artículos. Cinco artículos más de autores latinoamericanos o de habla hispana fueron también revisados por considerarlos pertinentes. Conclusiones: los pacientes con pancreatitis aguda grave se benefician del soporte nutricional y la vía entérica es de elección con dietas normocalóricas de inicio temprano, preferencialmente en los primeros tres días. La intervención nutricional pudiera ser un determinante al disminuir la morbilidad y la mortalidad elevada en esta patología pero aún faltan estudios bien diseñados que permitan determinar con claridad el efecto de cada uno de sus componentes.


Objective: to propose a clinical practice guideline of nutrition for patients with severe acute pancreatitis derived from the best available evidence. Design: systematic review and clinical practice guideline.Setting: critically ill patients at the intensive care unit. Patients: with severe acute pancreatitis. Intervention: enteral or parenteral nutrition. Glutamine or no glutamine. Arginine or no arginine. Omega 3 fatty acid or control. Outcome: mortality, pulmonary, catheter associated or pancreatic infection, sepsis, ICU or hospital length of stay.Methodology: medical database online search.Results: 765 initial references were filtered with key words and 69 remained. 5 other articles in Spanish were considered pertinent. Conclusions: patients with severe acute pancreatitis benefit from nutritional support, and isocaloric early enteral route is of choice during the first 3 days. Nutritional intervention could be a determinant in lowering the high morbidity and mortality rates linked with this entity, but well designed trials that elucidate the true individual effect of each constituent are scarce.


Subject(s)
Humans , Arginine , Enteral Nutrition , Glutamine , Pancreatitis , Parenteral Nutrition, Total , Probiotics
4.
Repert. med. cir ; 15(1): 29-35, 2006. tab, graf
Article in Spanish | LILACS, COLNAL | ID: lil-483578

ABSTRACT

El objetivo de esta investigación es determinar la adherencia a la guía de manejo clínico de lavado de manos por parte del personal de salud, después de la aplicación del sistema de vigilancia epidemiológica (SVE) en la unidad de cuidados intensivos (UCI) del Hospital de San José de Bogotá. Para conseguirlo se contó con un grupo de 33 individuos que conformaron la muestra. A este personal de salud se les aplicó una lista de chequeo e insumos obteniendo un diagnóstico inicial. Después se explicó el funcionamiento del SVE y se asignaron tareas. Luego se realizó un acompañamiento para solucionar inquietudes que surgieron en el diligenciamiento de las listas de verificación. A cada funcionario que labora en la UCI del Hospital de San José de Bogotá y que fue observado en el diagnóstico inicial, se le asignó un código que lo identificó de manera anónima y que lo ubicó en el semáforo epidemiológico, dependiendo del grado de adherencia de cada uno a la guía de lavado clínico de manos. Posterior a la implementación del SVE se aplicaron las mismas listas de verificación utilizadas en el diagnóstico inicial para determinar el comportamiento de la adherencia a la guía de lavado de manos, con los siguientes resultados: se observó un mejoramiento en la adherencia por parte de todo el personal de salud, donde las que menos fallaron fueron las enfermeras y las terapeutas y el número de ítems acertados llegó hasta 20, con lo cual se concluyó que el personal que labora en la UCI aunque se lava las manos, presenta deficiencias en la adherencia a la guía, las cuales son susceptibles de superarse con la aplicación continua del SVE. Aunque la práctica de lavado de manos es diaria, se deben realizar talleres de capacitación y evaluación periódica como lo estipula la guía de la Secretaría de Salud para garantizar la adherencia al 100%, pues el éxito del SVE depende de la motivación y aplicación continua por parte del personal. El control de la disponibilidad permanente de insumos, permite la exigencia del cumplimiento de la guía de manejo de lavado de manos.


Subject(s)
Humans , Male , Female , Health Surveillance System , Hand Disinfection , Health Personnel , Intensive Care Units
SELECTION OF CITATIONS
SEARCH DETAIL
...